Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 31 Colorectal Neoplasms 18 Carcinoma, Hepatocellular 18 Stomach Neoplasms 12 Esophageal Squamous Cell Carcinoma 12 Squamous Cell Carcinoma of Head and Neck 9 Neoplasm Metastasis 9 Advanced Solid Tumor 9 Lung Neoplasms 7 Head and Neck Neoplasms 7 Rectal Neoplasms 5 Esophageal Neoplasms 5 Small Cell Lung Carcinoma 4 Neoplasms 4 Nasopharyngeal Carcinoma 4 Melanoma 4 Solid Tumor 3 Lymphoma, Follicular 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Biliary Tract Neoplasms 3 Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma 2 Hodgkin Disease 2

Interventions

durvalumab 13 Bevacizumab 11 Nivolumab 10 tremelimumab 7 pembrolizumab 6 lenvatinib 6 fludarabine 6 Cyclophosphamide 6 atezolizumab 4 Radiosurgery 4 Cisplatin 4 toripalimab 3 relatlimab 3 Magnetic Resonance Imaging 3 Ipilimumab 3 Gemcitabine 3 X-Rays 2 Standard of Care 2 Sorafenib 2 Riluzole 2 Radiotherapy 2 Photons 2 Patient Navigation 2 Lidocaine 2 Hepatectomy 2 Dexamethasone 2 Biopsy 2 trastuzumab deruxtecan 1 tocilizumab 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × tislelizumab × 1 year × Clear all

NCT05532319 2025-12-30

FRONT-1

Guangxi Medical University

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡